Company bioMérieux

Equities

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris 16:35:26 17/07/2024 BST 5-day change 1st Jan Change
93.95 EUR +0.05% Intraday chart for bioMérieux +2.18% -6.61%

Business Summary

bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows:

- medical applications (84.4%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors;

- industrial applications (15.6%).

The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services.

Net sales are distributed geographically as follows: Europe/Middle East/Africa (32.4%), North America (44.1), Asia/Pacific (17.3%) and Latin America (6.2%).

Number of employees: 13,696

Sales per Business

EUR in Million2022Weight2023Weight Delta
Clinical Applications
84.3 %
3,040 84.7 % 3,099 84.3 % +1.95%
Industrial Applications
15.7 %
549 15.3 % 575 15.7 % +4.79%

Sales per region

EUR in Million2022Weight2023Weight Delta
Americas
50.2 %
1,841 51.3 % 1,846 50.2 % +0.26%
EMEA
26.3 %
901 25.1 % 965 26.3 % +7.05%
Asia Pacific
17.4 %
624 17.4 % 638 17.4 % +2.15%
France
6.1 %
220 6.1 % 226 6.1 % +2.64%
Corporate
0.0 %
3 0.1 % 1 0.0 % -65.38%

Managers

Managers TitleAgeSince
Chief Executive Officer 52 31/10/16
Chairman 50 15/04/04
Director of Finance/CFO 48 28/02/18
Chief Tech/Sci/R&D Officer - 31/07/23
Director/Board Member 74 14/09/06
Public Communications Contact - -
Corporate Officer/Principal - -
Corporate Officer/Principal 44 31/12/10
Corporate Officer/Principal 58 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 74 14/09/06
Director/Board Member 63 31/12/04
Chairman 50 15/04/04
Director/Board Member 59 29/05/12
Director/Board Member 59 29/05/12
Director/Board Member 45 29/06/17
Director/Board Member 68 27/08/17
Director/Board Member - 23/05/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 118,361,220 42,884,007 ( 36.23 %) 206,987 ( 0.1749 %) 36.23 %

Shareholders

NameEquities%Valuation
Compagnie Merieux Alliance SAS
58.90 %
69,720,270 58.90 % 6 632 M €
4,493,520 3.796 % 427 M €
Sofina SA (Private Equity)
1.928 %
2,282,513 1.928 % 217 M €
Oddo BHF Asset Management SAS
1.265 %
1,497,323 1.265 % 142 M €
bioMérieux SA Employee Stock Ownership Plan
0.8359 %
989,348 0.8359 % 94 M €
DNCA Finance SA
0.4779 %
565,630 0.4779 % 54 M €
Eleva Capital SAS
0.2820 %
333,732 0.2820 % 32 M €
Zadig Asset Management LLP
0.2797 %
331,000 0.2797 % 31 M €
Crédit Mutuel Asset Management SA
0.2626 %
310,789 0.2626 % 30 M €
Devon Equity Management Ltd.
0.2404 %
284,562 0.2404 % 27 M €

Holdings

NameEquities%Valuation
59,062,832 6.76% 70,480,268 $
201,318 0.17% 19,148,927 $

Company contact information

bioMérieux SA

376, chemin de l'Orme

69280, Marcy l'Etoile

+33 4 78 87 20 00

http://www.biomerieux.com
address bioMérieux(BIM)

Group companies

NameCategory and Sector
Medical Specialties
Medical Distributors
bioMérieux Asia Pacific Pte Ltd.
Medical Specialties
bioMérieux Sweden AB
Medical Specialties
Electronic Production Equipment
Packaged Software
Medical Specialties